Status:
UNKNOWN
Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall Recurrence
Lead Sponsor:
KK Women's and Children's Hospital
Conditions:
Breast Cancer
Recurrent Disease
Eligibility:
FEMALE
18-100 years
Brief Summary
The axillary management of breast cancer patients with operable isolated chest wall recurrence after mastectomy is unclear. We aim to determine if axillary restaging surgery can be safely omitted with...
Eligibility Criteria
Inclusion
- Mastectomy patients who developed pathologically confirmed invasive isolated chest wall recurrence.
- \-
Exclusion
- Patients with bilateral cancers
- Patients with evidence of concomitant distant or/and regional recurrences
- Patients who did not have surgery for their isolated chest wall recurrences.
Key Trial Info
Start Date :
January 1 1989
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06088719
Start Date
January 1 1989
End Date
December 31 2024
Last Update
October 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KK Women's and Children's Hospital
Singapore, Singapore